Benign prostatic hyperplasia (BPH) nodule is the most common benign prostatic lesion developing in the transition zone, seen in more than 50% of men over 50 years old. BPH results from hyperplasia of glandular and stromal elements in the transitional and periurethral zones of the prostate. Histologically, it can be glandular, stromal (fibromuscular), or mixed type. On mpMRI, it creates a heterogeneous but organized pattern in the transition zone ('organized chaos' appearance). BPH nodules are well-circumscribed and frequently appear as encapsulated, round lesions on T2-weighted images. Clinically, it causes lower urinary tract symptoms (LUTS): frequency, nocturia, weak stream, and incomplete bladder emptying. PSA levels may be mildly elevated proportional to prostate volume, but PSA density is typically low (<0.15 ng/mL/cc). BPH nodules require careful evaluation as they can mimic transition zone adenocarcinoma.
Age Range
50-80
Peak Age
65
Gender
Male predominant
Prevalence
Very Common
BPH develops from androgen-dependent proliferation of stromal and epithelial cells in the transitional and periurethral zones. Dihydrotestosterone (DHT), converted from testosterone by 5-alpha reductase enzyme, is the primary stimulator of prostate cell growth. Histologically, glandular-type nodules contain more cystically dilated glands and appear hyperintense on T2 — this results from free water molecules in fluid-filled glandular lumens having long T2 relaxation times. Stromal-type nodules are predominantly composed of fibrous and smooth muscle tissue, therefore showing low signal on T2 — collagen and muscle fibers dephase rapidly due to their short T2 relaxation times. This creates the characteristic 'organized chaos' appearance in the transition zone on mpMRI: multiple nodules of different histological composition lie side by side, each showing different signal intensity but remaining well-circumscribed and encapsulated. The critical finding for differentiating BPH nodules from adenocarcinoma is the 'erased charcoal sign' — TZ cancer erases the boundaries of BPH nodules and creates homogeneous low T2 signal. On DWI, BPH nodules generally do not show significant diffusion restriction because cells are organized and regularly arranged without increased cellularity; whereas adenocarcinoma narrows the extracellular space through dense cell packing, causing diffusion restriction.
Heterogeneous but organized pattern on T2-weighted MRI formed by multiple well-circumscribed, encapsulated nodules of different signal intensity in the transition zone. Each nodule has different histological composition (glandular vs stromal) and produces different T2 signal, but all nodules have sharp borders and capsules. This pattern is specific to BPH and is critical in differential diagnosis from adenocarcinoma (homogeneous low T2 signal, 'erased charcoal sign' obliterating borders).
Multiple well-circumscribed nodules in transition zone, each with different signal intensity — glandular nodules T2 hyperintense (fluid-filled glands), stromal nodules T2 hypointense (fibrous tissue). Thin hypointense capsules and normal TZ tissue visible between nodules. This 'organized chaos' pattern is the typical appearance of BPH and is defined as regular heterogeneity. Nodules are encapsulated and round/oval shaped, growing by displacing each other. Overall prostate size is increased and peripheral zone may be compressed.
Report Sentence
Multiple well-circumscribed, encapsulated nodules of varying signal intensity are noted in the transition zone, consistent with the 'organized chaos' pattern of benign prostatic hyperplasia.
BPH nodules generally do not show significant diffusion restriction on DWI. Glandular nodules may appear hyperintense on DWI due to T2 shine-through effect but no signal drop is seen on ADC map (ADC typically >1000-1200 × 10⁻⁶ mm²/s). Stromal nodules show low-to-intermediate signal on DWI. In the presence of marked focal diffusion restriction (ADC <800 × 10⁻⁶ mm²/s), TZ adenocarcinoma should be excluded.
Report Sentence
No significant diffusion restriction is observed in the transition zone nodules with ADC values within normal range, consistent with benign prostatic hyperplasia.
BPH nodules typically show normal or mildly reduced ADC values on ADC map (>1000-1200 × 10⁻⁶ mm²/s). Glandular-type nodules show higher ADC values (fluid-containing glands), while stromal-type nodules may show lower ADC values (600-1000 × 10⁻⁶ mm²/s). ADC values of stromal BPH nodules may overlap with TZ adenocarcinoma — in this case, T2 morphology and presence of 'erased charcoal sign' are critical for differential diagnosis. According to PI-RADS v2.1, primary assessment in TZ lesions is based on T2 morphology, DWI/ADC serves only as an upgrading criterion.
Report Sentence
No markedly low ADC values are detected in the transition zone nodules on ADC map, consistent with benign prostatic hyperplasia.
BPH nodules show variable enhancement on DCE (dynamic contrast-enhanced) MRI. Glandular nodules typically show progressive, slow enhancement, while stromal nodules may demonstrate more prominent early enhancement. Importantly, enhancement in BPH nodules tends to be diffuse and symmetric rather than focal and asymmetric. According to PI-RADS v2.1, DCE is NOT the primary criterion for evaluation of transition zone lesions — it only plays an upgrading role in peripheral zone lesions. If focal, early, and intense enhancement is present in TZ, PI-RADS score may be upgraded, but the primary decision is based on T2 morphology.
Report Sentence
Diffuse, symmetric enhancement is observed in transition zone nodules on DCE series without focal early enhancement; this pattern is consistent with BPH.
On transrectal ultrasonography (TRUS), BPH nodules appear as heterogeneous echogenicity nodules in the transition zone enlarging the prostate. Glandular nodules show hypoechoic or mixed echogenicity, while stromal nodules may be hyperechoic. Prostate volume is increased (typically >30 mL). Intravesical protrusion (median lobe hyperplasia) may be visible. BPH nodules are generally well-circumscribed and separated from peripheral zone by surgical capsule. TRUS is the primary modality for prostate volume measurement and PSA density calculation but limited in lesion characterization compared to mpMRI.
Report Sentence
Prostate dimensions are increased on TRUS (volume: ___ mL) with multiple well-circumscribed, heterogeneous echogenicity nodules in the transition zone; findings are consistent with BPH.
CT evaluates prostate enlargement but detailed characterization of BPH nodules is limited. On non-contrast CT, prostate dimensions are increased and may show mildly heterogeneous density in the transition zone. Coarse calcifications or corpora amylacea (age-related physiological calcifications) may be seen. CT is not the primary modality for BPH diagnosis but may be incidentally detected on CT performed for other reasons. Obstructive complications such as intravesical protrusion (median lobe) and bilateral hydroureteronephrosis can be evaluated.
Report Sentence
Prostate dimensions are increased on CT (anteroposterior diameter: ___ mm) with median lobe hyperplasia protruding into the bladder; findings are consistent with BPH.
Criteria
Glandular component predominant, contains cystically dilated glands
Distinct Features
Hyperintense on T2, high ADC, slow progressive enhancement, hypoechoic or mixed on TRUS
Criteria
Fibromuscular stroma predominant, few glandular elements
Distinct Features
Hypointense on T2 — may be confused with TZ cancer but encapsulated and round, mildly low ADC (600-1000), may show early enhancement, hyperechoic on TRUS
Criteria
Glandular and stromal elements combined, most common type
Distinct Features
Heterogeneous signal on T2 (hyper and hypointense areas together), variable ADC, mixed enhancement pattern characteristics
Criteria
Periurethral/median location, protrusion into bladder base
Distinct Features
Protrusion into bladder base, high risk of obstructive uropathy, nodule extending into bladder on TRUS and MRI, may cause bilateral hydronephrosis
Distinguishing Feature
TZ adenocarcinoma shows homogeneous low signal on T2 with 'erased charcoal sign' — erasing boundaries of BPH nodules. In BPH, nodules are encapsulated with preserved borders. Adenocarcinoma shows marked restriction on DWI (ADC <800) and lenticular/homogeneous morphology.
Distinguishing Feature
Prostatitis shows diffuse or focal T2 hypointensity with wedge-shaped enhancement, does not demonstrate the nodular and encapsulated pattern of BPH. Clinically, prostatitis is accompanied by fever, dysuria, and pain; PSA can be very elevated but clinical correlation is required.
Distinguishing Feature
Leiomyoma is a rare, solitary, homogeneous T2 hypointense mass that can mimic stromal BPH nodule. However, leiomyoma is typically a single lesion while BPH is multinodular. Leiomyoma generally has no DWI restriction and overall prostate volume is not increased.
Distinguishing Feature
Anterior fibromuscular stroma (AFMS) is a normal anatomical structure showing homogeneous low signal on T2. Unlike BPH nodules, AFMS is anteriorly located, does not show encapsulated nodular architecture, and does not increase prostate size.
Urgency
routineManagement
conservativeBiopsy
Not NeededFollow-up
annualBPH is a benign condition with no malignancy risk. Treatment is determined by LUTS severity: watchful waiting for mild symptoms, medical therapy with alpha-blockers (tamsulosin, alfuzosin) or 5-alpha reductase inhibitors (finasteride, dutasteride) for moderate symptoms, surgery (TURP, HoLEP, prostatectomy) for severe symptoms or complications (retention, hydronephrosis, recurrent UTI). Biopsy is not needed if PSA density <0.15 and PI-RADS 1-2. For PI-RADS 3 TZ lesions, PSA density and clinical risk factors should be evaluated.
BPH nodules are benign with no risk of malignant transformation. They may cause lower urinary tract symptoms (LUTS). Medical treatment (alpha-blockers, 5-alpha reductase inhibitors) or surgery (TURP) is applied in symptomatic patients. Differentiation from cancer on mpMRI is critically important.